跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATIN-WGR atorvastatin (as calcium trihydrate) 20 mg tablets bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ATORVASTATIN-WGR atorvastatin (as calcium trihydrate) 20 mg tablets bottle
Approved
STANDARD
ATORVASTATIN-WGR atorvastatin (as calcium trihydrate) 20 mg tablets bottle
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fb987958134ef06f
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
fb987958134ef06f
Product Name
ATORVASTATIN-WGR atorvastatin (as calcium trihydrate) 20 mg tablets bottle
Artg Id
431459
Artg Name
ATORVASTATIN-WGR atorvastatin (as calcium trihydrate) 20 mg tablets bottle
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2024-05-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02532-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fb987958134ef06f
Type
Standard
Back to TGA Approvals